Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Ann Biomed Eng. 2015 Nov 24;44(7):2189–2201. doi: 10.1007/s10439-015-1517-y

Fig. 6.

Fig. 6

Effects of heparinase on ESG of EC monolayers and tumor cell adhesion. Confocal images showing AF488-anti-HS labeled ESG (green) on bEnd3 monolayers under control (A) and after 1 h 50 mU/mL heparinase III pretreatment (B). 1 h tumor cell adhesion under control (C) and that after 1 h heparinase III pretreatment (D). Comparison of the intensity of AF488-anti-HS labeled ESG on bEnd3 monolayers and the number of adherent tumor cells under control and after 1 h heparinase pretreatment (E). * p < 0.05, compared with the control. n = 3, Values are means ± SE.